NCT01129882: A reported trial by Otsuka Pharmaceutical Development & Commercialization, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01129882 |
|---|---|
| Title | An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Patients With Schizophrenia |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 24, 2010 |
| Completion date | Dec. 6, 2018 |
| Required reporting date | Dec. 6, 2019, midnight |
| Actual reporting date | Nov. 15, 2019 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |